This content originally appeared on HIV.Gov. View the full article here.

Summary: New CDC funding will support efforts in EHE jurisdictions to increase PrEP access and uptake among priority populations disproportionately affected by HIV and low PrEP prescriptions.

The Centers for Disease Control and Prevention (CDC) recently issued a new competitive supplemental funding opportunity to increase PrEP access and uptake among priority populations and eliminate structural and social barriers that prevent equitable access to PrEP within EHE jurisdictions. The new funding opportunity is open to the health departments currently receiving funding for the Ending the HIV Epidemic in the U.S. (EHE) initiative through PS24-0047: High-Impact HIV Prevention and Surveillance Programs for Health Departments. This supplemental program aims to accelerate progress toward meeting the National HIV/AIDS Strategy (2022-2025) and EHE goal of 50% PrEP coverage by the end of 2025.

CDC expects to award approximately $7 million to up to four health departments to support efforts to accelerate PrEP uptake focused on priority populations disproportionately affected by HIV and low PrEP prescriptions (i.e., Black and Latino gay, bisexual, and other men who have sex with men, and Black cisgender and transgender women) through patient navigation/case management services and improved access to and utilization of existing PrEP services not covered by other financial resources.

In addition to increasing PrEP access and uptake, these programs will incorporate elements to increase HIV non-occupational post-exposure prophylaxis (PEP) and STI doxycycline post-exposure prophylaxis (doxy PEP) awareness and access, including activities with clinicians, non-clinical community-based organizations, and persons at risk for HIV acquisition.

Applications are due by August 31, 2024.